0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Single Use Bioreactors"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Single-Use Bioreactors - Global Strategic Business Report - Product Thumbnail Image

Single-Use Bioreactors - Global Strategic Business Report

  • Report
  • March 2025
  • 246 Pages
  • Global
From
EUR$4,950USDGBP
Single-Use Bio Reactors Market Report 2025 - Product Thumbnail Image

Single-Use Bio Reactors Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Single-Use Bioreactors Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Single-Use Bioreactors Market - Forecasts from 2024 to 2029

  • Report
  • April 2024
  • 114 Pages
  • Global
From
EUR$3,950USDGBP
Single-Use Bioreactor Market Report and Forecast 2024-2032 - Product Thumbnail Image

Single-Use Bioreactor Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
EUR$4,949USDGBP
EUR$2,450USDGBP
Single-use Technologies for Biopharmaceuticals Market - Product Thumbnail Image

Single-use Technologies for Biopharmaceuticals Market

  • Report
  • November 2024
  • 207 Pages
  • Global
From
EUR$4,650USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Loading Indicator

Single Use Bioreactors (SUBs) are bioreactors that are designed for a single use and then disposed of. They are used in biotechnology for the production of biopharmaceuticals, such as vaccines, monoclonal antibodies, and recombinant proteins. SUBs are typically made of plastic and are pre-sterilized, eliminating the need for cleaning and sterilization between batches. This makes them ideal for rapid scale-up and production of biopharmaceuticals. SUBs also offer advantages such as reduced risk of contamination, improved process control, and reduced capital costs. The SUB market is growing rapidly due to the increasing demand for biopharmaceuticals and the need for rapid scale-up and production. SUBs are becoming increasingly popular in the biotechnology industry due to their cost-effectiveness and convenience. Some companies in the SUB market include Sartorius, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, and Pall Corporation. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more